LiveWorld Reports Third Quarter 2025 Financial Results
LiveWorld (OTC: LVWD) reported Q3 2025 results on November 13, 2025: Total revenue $2.84M (healthcare revenue $2.6M) and net income $195K for the quarter. Q3 revenue declined ~9% versus Q3 2024 and nine-month revenue was $8.07M versus $8.49M a year earlier. The company ended Q3 with $7.69M cash and cash equivalents and defined net cash available for operations of $6.0M. Deferred revenue and current liabilities rose materially versus year-end 2024. Management reiterated continued investments in AI and product development while noting market uncertainty and potential impacts on future earnings.
LiveWorld (OTC: LVWD) ha riportato i risultati del terzo trimestre 2025 il 13 novembre 2025: entrate totali di 2,84 milioni di dollari (entrate nel settore sanitario 2,6 milioni) e utile netto di 195 mila dollari per il trimestre. Le entrate del Q3 sono diminuite di circa il 9% rispetto al Q3 2024 e le entrate dei primi nove mesi sono state 8,07 milioni di dollari rispetto agli 8,49 milioni dell'anno precedente. L'azienda ha chiuso il Q3 con 7,69 milioni di dollari in contanti e equivalenti e ha definito la disponibilità netta di cassa operativa di 6,0 milioni. Le entrate differite e le passività correnti sono aumentate in modo significativo rispetto alla chiusura al 2024. La direzione ha ribadito gli investimenti continui in IA e nello sviluppo del prodotto, pur osservando l'incertezza del mercato e i potenziali impatti sui futuri guadagni.
LiveWorld (OTC: LVWD) presentó los resultados del tercer trimestre de 2025 el 13 de noviembre de 2025: ingresos totales de $2.84M (ingresos en atención médica $2.6M) y utilidad neta de $195K para el trimestre. Los ingresos del tercer trimestre cayeron aproximadamente un 9% frente al tercer trimestre de 2024 y los ingresos de los nueve meses fueron $8.07M frente a $8.49M del año anterior. La empresa cerró el tercer trimestre con $7.69M en efectivo y equivalentes y definió disponible neto de efectivo para operaciones de $6.0M. Los ingresos diferidos y los pasivos corrientes aumentaron notablemente con respecto a fines de 2024. La dirección reiteró las inversiones continuas en IA y desarrollo de productos, al tiempo que señaló la incertidumbre del mercado y posibles impactos en las ganancias futuras.
LiveWorld (OTC: LVWD)는 2025년 11월 13일 2025년 3분기 실적을 발표했습니다: 총 매출 284만 달러 (의료 분야 매출 260만 달러) 및 분기 순이익 19.5만 달러. 3분기 매출은 2024년 3분기 대비 약 9% 감소했고, 9개월 누적 매출은 807만 달러로 전년동기의 849만 달러였던 것에 비해 감소했습니다. 회사는 3분기를 현금 및 현금성 자산 769만 달러으로 마감했고, 영업활동으로 사용할 수 있는 순현금액을 600만 달러로 정의했습니다. 연기 매출과 유동부채는 2024년 말 대비 크게 증가했습니다. 경영진은 AI와 제품 개발에 대한 지속적인 투자를 재확인했으며, 시장의 불확실성과 향후 수익에 미칠 수 있는 잠재적 영향에 주목했습니다.
LiveWorld (OTC: LVWD) a publié les résultats du troisième trimestre 2025 le 13 novembre 2025 : un chiffre d'affaires total de 2,84 millions de dollars (chiffre d'affaires dans le secteur des soins de santé de 2,6 millions) et un résultat net de 195 000 dollars pour le trimestre. Les revenus du T3 ont diminué d'environ 9% par rapport au T3 2024 et le chiffre d'affaires des neuf premiers mois était de 8,07 millions de dollars contre 8,49 millions l'année précédente. L'entreprise a terminé le T3 avec 7,69 millions de dollars en liquidités et équivalents et a défini une disponibilité nette de trésorerie pour les opérations de 6,0 millions. Les revenus différés et les passifs courants ont fortement augmenté par rapport à la fin de 2024. La direction a réitéré les investissements continus dans l'IA et le développement produit tout en notant l'incertitude du marché et les impacts potentiels sur les bénéfices futurs.
LiveWorld (OTC: LVWD) hat am 13. November 2025 die Ergebnisse für das dritte Quartal 2025 veröffentlicht: Gesamtumsatz 2,84 Mio. USD (Umsatz im Gesundheitswesen 2,6 Mio. USD) und Nettoeinkommen 195 Tsd. USD für das Quartal. Der Umsatz im Q3 ging gegenüber Q3 2024 um ca. 9% zurück, und der Umsatz für die neun Monate lag bei 8,07 Mio. USD gegenüber 8,49 Mio. USD im Vorjahr. Das Unternehmen schloss das Q3 mit 7,69 Mio. USD Bargeld und Barmitteläquivalente und definierte die liquide Mittel für Betriebe in Höhe von 6,0 Mio. USD. Forderungen aus Lieferungen und Leistungen und Verbindlichkeiten aus Lieferungen und Leistungen sind im Vergleich zum Jahresende 2024 deutlich gestiegen. Die Geschäftsführung bekräftigte weiterhin Investitionen in KI und Produktentwicklung, wies jedoch auf Marktunsicherheit und potenzielle Auswirkungen auf künftige Erträge hin.
LiveWorld (OTC: LVWD) أصدرت نتائج الربع الثالث من عام 2025 في 13 نوفمبر 2025: إجمالي الإيرادات 2.84 مليون دولار (إيرادات الرعاية الصحية 2.6 مليون) وصافي الربح 195 ألف دولار لهذا الربع. انخفضت إيرادات الربع الثالث بنحو 9% مقارنةً بالربع الثالث من 2024، وكانت إيرادات تسعة الأشهر 8.07 مليون دولار مقابل 8.49 مليون دولار في العام السابق. أنهت الشركة الربع الثالث بـ7.69 مليون دولار من النقد وما يعادله وعرفت عن النقد المتاح للتشغيل بقيمة 6.0 مليون دولار. زادت الإيرادات المؤجلة والالتزامات الجارية بشكل ملموس مقارنة بنهاية عام 2024. أكدت الإدارة استمرار الاستثمارات في الذكاء الاصطناعي وتطوير المنتج مع الإشارة إلى عدم اليقين في السوق والتأثيرات المحتملة على الأرباح المستقبلية.
- Net income of $195K in Q3 2025
- Cash and cash equivalents increased to $7.7M (from $6.6M)
- Net cash available for operations of $6.0M
- Nine-month net loss reduced by ~49% versus prior year
- Income from operations decreased to $167K from $291K (~43% drop)
- Deferred revenue rose to $2.03M from $0.86M (increase may pressure delivery)
- Total liabilities increased to $4.63M from $2.52M at year-end 2024
- Accounts receivable increased to $1.76M from $0.68M (larger receivables balance)
LiveWorld continues to increase its AI investment
CAMPBELL, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for third quarter 2025.
Q3 2025 Financial and Business Highlights
- Total three months revenues of
$2.8 million - Healthcare revenues of
$2.6 million in Q3 2025 - Net income from operations of
$195,000 - Net Cash of
$6.0 million
Management Commentary
“Our third quarter of 2025 saw a reduction of total revenues when compared to the same quarter of 2024 of approximately
The Company said it will continue to look to make increased investments in its AI programs which may impact future earnings.
“AI isn’t replacing people — Done best, it’s elevating them. LiveWorld is investing in AI enablement across the agency and launching AI solutions that give healthcare marketers clarity instead of complexity, insight instead of noise, and more value for their money,” said Peter Friedman, Chairman and CEO, LiveWorld. “We are defining what it means to use AI responsibly: human intelligence in the lead, AI amplifying the work. That’s how we help brands engage safely, authentically, and with greater results.”
Financial Review for the Three and Nine Months Ended September 30, 2025
Total revenues for the three months ended September 30, 2025 were approximately
Total revenues for the nine months ended September 30, 2025 were approximately
The company reported a net income for the three months of approximately
The company reported a net loss for the nine months of approximately
The company finished the quarter with approximately
Detailed financial information may be downloaded at www.liveworld.com/ir or at https://www.otcmarkets.com/stock/LVWD/overview.
About LiveWorld
LiveWorld is a social-first digital agency and software company that unlocks the full potential of social media to transform customer relationships through integrated compliance, engagement, and insight solutions. We provide brand marketers bold creative rooted in strategy that captivates and resonates, social moderation and engagement that activates interactions, software and AI that enriches and scales customer experiences, and compliance that enables and accelerates digital programs.
With over 29 years of making connections, we leverage our social media DNA to deliver emotion-driven behavior change through digital campaigns with a human touch. LiveWorld clients include the number one brands in pharmaceuticals, healthcare, and financial-travel services. LiveWorld is headquartered in Campbell, California, with an additional office in New York City. Learn more at www.liveworld.com and @LiveWorld.
“Safe Harbor" Statement Under The Private Securities Litigation Reform Act
This press release may contain forward-looking information concerning LiveWorld plans, objectives, future expectations, forecasts and prospects. These statements may include those regarding LiveWorld’s current or future financial performance including but not limited to lists of clients, revenue and profit, use of cash, investments, relationships and the actual or potential impact of stock option expense, and the results of its product development efforts. Actual results may differ materially from those expressed in the forward- looking statements made as a result of, among other things, final accounting adjustments and results, LiveWorld’s ability to attract new clients and preserve or expand its relationship with existing clients, LiveWorld’s ability to retain and attract high quality employees, including its management staff, the ability to deliver new innovative products in a timely manner, changing accounting treatments, and other risks applicable to the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to update these forward-looking statements to reflect subsequent events or circumstances.
LiveWorld Contacts
IR Contact:
David Houston
LiveWorld
dhouston@liveworld.com
(408) 615-8496
PR Contact:
Matthew Hammer
LiveWorld
mhammer@liveworld.com
(737) 212-9739
| LIVEWORLD, INC. | |||||||
| UNAUDITED CONDENSED BALANCE SHEETS | |||||||
| (In thousands, except share data) | |||||||
| September 30 | December 31, | ||||||
| 2025 | 2024 | ||||||
| ASSETS | |||||||
| Current assets | |||||||
| Cash and cash equivalent | $ | 7,685 | $ | 6,603 | |||
| Accounts receivable, net | 1,761 | 682 | |||||
| Prepaid expenses | 315 | 290 | |||||
| Total current assets | 9,761 | 7,575 | |||||
| Property and equipment, net | 21 | 33 | |||||
| Other assets | 27 | 27 | |||||
| Total assets | $ | 9,809 | $ | 7,635 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 320 | $ | 182 | |||
| Accrued employee expenses | 605 | 1,068 | |||||
| Other accrued liabilities | 1,671 | 413 | |||||
| Deferred revenue | 2,031 | 860 | |||||
| Total current liabilities | 4,627 | 2,523 | |||||
| Total liabilities | 4,627 | 2,523 | |||||
| Stockholders' equity | |||||||
| Common stock: | 34 | 34 | |||||
| Additional paid-in capital | 144,693 | 144,451 | |||||
| Accumulated deficit | (139,545 | ) | (139,373 | ) | |||
| Total stockholders' equity | 5,182 | 5,112 | |||||
| Total liabilities and stockholders' equity | $ | 9,809 | $ | 7,635 | |||
| LIVEWORLD, INC. | |||||||||||||||
| CONDENSED STATEMENT OF OPERATIONS | |||||||||||||||
| (In thousands, except per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Total revenues | $ | 2,842 | $ | 3,131 | $ | 8,073 | $ | 8,490 | |||||||
| Cost of revenues | 1,335 | 1,558 | 4,171 | 4,702 | |||||||||||
| Gross Margin | 1,507 | 1,573 | 3,902 | 3,788 | |||||||||||
| Operating Expense | |||||||||||||||
| Product development | 359 | 294 | 996 | 811 | |||||||||||
| Sales and marketing | 369 | 301 | 1,264 | 1,271 | |||||||||||
| General and administrative | 612 | 687 | 1,860 | 2,028 | |||||||||||
| Total operating expense | 1,340 | 1,282 | 4,120 | 4,110 | |||||||||||
| Income from operations | 167 | 291 | (218 | ) | (322 | ) | |||||||||
| Income before tax | 167 | 291 | (218 | ) | (322 | ) | |||||||||
| Other Income | 32 | 1 | 69 | 4 | |||||||||||
| Provision for income taxes | 4 | 1 | 23 | 23 | |||||||||||
| Net income from operations | 195 | 291 | (172 | ) | (341 | ) | |||||||||
| Earnings per share analysis from operations: | |||||||||||||||
| Basic income per share | $ | 0.00 | $ | 0.01 | $ | (0.00 | ) | $ | (0.01 | ) | |||||
| Shares used in computing basic loss per share | 45,633,442 | 45,633,442 | 45,633,442 | 45,633,442 | |||||||||||
| Diluted net income (loss) per share | $ | 0.00 | $ | 0.01 | $ | (0.00 | ) | $ | (0.01 | ) | |||||
| Shares used in computing diluted income (loss) per share | 54,992,048 | 55,116,047 | 45,633,442 | 45,633,442 | |||||||||||
| Departmental allocation of stock-based compensation: | |||||||||||||||
| Cost of revenues | $ | 21 | $ | 21 | $ | 62 | $ | 58 | |||||||
| Product development | 6 | 5 | 15 | 14 | |||||||||||
| Sales and marketing | 8 | 8 | 24 | 25 | |||||||||||
| General and administrative | 47 | 49 | 141 | 142 | |||||||||||
| Total stock-based compensation | $ | 82 | $ | 83 | $ | 242 | $ | 239 | |||||||
| LIVEWORLD, INC. | |||||||||||||||
| CONDENSED STATEMENTS OF CASH FLOWS | |||||||||||||||
| (In thousands) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Cash flows from operating activities: | |||||||||||||||
| Net income (loss) | $ | 195 | $ | 291 | $ | (172 | ) | $ | (341 | ) | |||||
| Adjustments to reconcile net income (loss) provided by (used in) operating activities: | |||||||||||||||
| Depreciation of long-lived assets | 5 | 6 | 16 | 19 | |||||||||||
| Stock-based compensation | 82 | 83 | 242 | 239 | |||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||
| Accounts receivable | 2,118 | 452 | (1,079 | ) | 72 | ||||||||||
| Other assets | 9 | (43 | ) | (24 | ) | (43 | ) | ||||||||
| Accounts payable | 103 | (45 | ) | 138 | (61 | ) | |||||||||
| Accrued liabilities | (13 | ) | 641 | 794 | 436 | ||||||||||
| Deferred revenue | (352 | ) | 13 | 1,171 | 1,220 | ||||||||||
| Net cash provided by (used in) operating activities | 2,147 | 1,398 | 1,086 | 1,541 | |||||||||||
| Cash flows from investing activities: | |||||||||||||||
| Purchase of property and equipment | ----- | (6 | ) | (4 | ) | (12 | ) | ||||||||
| Net cash provided by (used in) investing activities | ----- | (6 | ) | (4 | ) | (12 | ) | ||||||||
| Cash flows from financing activities: | |||||||||||||||
| Proceeds from exercise of stock options | ----- | ---- | ----- | ---- | |||||||||||
| Net cash provided by (used for) financing activities | ----- | ---- | ----- | ---- | |||||||||||
| Change in cash and cash equivalent | 2,147 | 1,392 | 1,082 | 1,529 | |||||||||||
| Cash and cash equivalents, beginning of period | 5,538 | 4,772 | 6,603 | 4,635 | |||||||||||
| Cash and cash equivalents, end of period | $ | 7,685 | $ | 6,164 | $ | 7,685 | $ | 6,164 | |||||||
| Supplemental disclosure of non-cash financing and investing activities: | |||||||||||||||
| Income tax paid | $ | 4 | $ | 1 | $ | 23 | $ | 23 | |||||||